Definition, epidemiology and natural history of COPD

European Respiratory Journal

Volumn 30, Issue 5, 2007, Pages 993-1013

  Viegi, G ^a,c   Pistelli, F ^a   Sherrill, D L ^a,b   Maio, S ^a   Baldacci, S ^a   Carrozzi, L ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF ARIZONA   (United States)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Air pollution; Chronic obstructive pulmonary disease clinical basic investigations; Cor pulmonale; Epidemiology of asthma chronic obstructive pulmonary disease; Smoking; Spirometry

Indexed keywords

AIR POLLUTION; AIRWAY OBSTRUCTION; ALPHA ANTITRYPSIN DEFICIENCY; ASSISTED VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL FEATURE; COMORBIDITY; COUGHING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEALTH CARE COST; HUMAN; LONG TERM CARE; MORTALITY; OCCUPATIONAL EXPOSURE; OXYGEN THERAPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SMOKING CESSATION; SOCIAL STATUS; SPUTUM;

COMORBIDITY; DISEASE PROGRESSION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INCIDENCE; MASS SCREENING; PHYSICAL EXAMINATION; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WORLD HEALTH;

EID: 38849185354     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00082507     Document Type: Review

References (221)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757.
2. Niederlander E. Cause of death in the EU. Statistics in focus - Population and social conditions. Eurostat (European Communities) 2006; 101: 1-12.
3. Jensen HH, Godtfredsen NS, Lange P, Vestbo J. Potential misclassification of causes of death from COPD. Eur Respir J 2006; 28: 781-785.
4. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22: 809-814.
5. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
6. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
7. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. www.goldcopd.com. Date last accessed: June 30, 2007. Date last updated: 2006.
8. Bousquet J, Dahl R, Khaltaev N. Global Alliance against Chronic Respiratory Diseases. Eur Respir J 2007; 29: 233-239.
9. Loddenkemper R, Gibson GJ, SibilleY, eds. European Respiratory Society/European Lung Foundation. European Lung White Book. The First Comprehensive Survey on Respiratory Health in Europe. Sheffield, ERSJ, 2003; pp. 34-43.
10. MacNee W, Viegi G, Kamel N. New opportunities for respiratory research in Europe: FP7. Eur Respir J 2007; 29: 223-225.
11. Siafakas NM. Definition and differential diagnosis of chronic obstructive pulmonary disease. In: Siafakas NM, ed. Management of Chronic Obstructive Pulmonary Disease. Eur Respir Mon 2006; 38: 1-6.
12. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease, American Thoracic Society. Am J Respir Crit Care Med 1995; 152: S77-S121.
13. Stuart B, Alexander C, Arenella C. Medical Guidelines for Determining Prognosis in Selected Non-Cancer Diseases. 2nd Edn. Arlington, National Hospice and Palliative Care Organization, 1996.
14. Klimathianaki M, Mitrouska I, Georgopoulos D. Management of end-stage chronic obstructive pulmonary disease. In: Siafakas NM, ed. Management of Chronic Obstructive Pulmonary Disease. Eur Respir Mon 2006; 38: 430-450.
15. Chan-Yeung M, Ait-Khaled N, White N, Ip MS, Tan WC. The burden and impact of COPD in Asia and Africa. Int J Tuberc Lung Dis 2004; 8: 2-14.
16. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22: 268-273.
17. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523-532.
18. Boutin-Forzano S, Moreau D, Kalaboka S, et al. Reported prevalence and co-morbidity of asthma, chronic bronchitis and emphysema: a pan-European estimation. Int J Tuberc Lung Dis 2007; 11: 695-702.
19. Murtagh E, Heaney L, Gingles J, et al. Prevalence of obstructive lung disease in a general population sample: the NICECOPD study. Eur J Epidemiol 2005; 20: 443-453.
20. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-1881.
21. Schirnhofer L, Lamprecht B, Vollmer WM, et al. COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. Chest 2007; 131: 29-36.
22. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188-207.
23. Viegi G, Pedreschi M, Pistelli F, et al. Prevalence of airways obstruction in a general population. European Respiratory Society vs American Thoracic Society definition. Chest 2000; 117: Suppl. 2, 339S-345S.
24. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003; 123: 1684-1692.
25. Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005; 127: 1544-1552.
26. Lindberg A, Eriksson B, Larsson LG, Rönmark E, Sandström T, Lundbäck B. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest 2006; 129: 879-885.
27. Johannessen A, Omenaas E, Bakke P, Gulsvik A. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis 2005; 9: 926-932.
28. Pelkonen M, Notkola IL, Nissinen A, Tukiainen H, Koskela H. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006; 130: 1129-1137.
29. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61: 935-939.
30. Lindberg A, Bjerg-Bäcklund A, Rönmark E, Larsson LG, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006; 100: 264-272.
31. Zielinski J, Bednarek M, Górecka D, et al. Increasing COPD awareness. Eur Respir J 2006; 27: 833-852.
32. Bates DV. Chronic bronchitis and emphysema. In: Macklem PT and Permutt S, eds. The Lung in the Transition Between Health and Disease. Vol. 12. New York, Marcel Dekker Inc., 1979; pp. 1-13.
33. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648.
34. Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97: 115-122.
35. Mannino DM, Watt G, Hole D, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 627-643.
36. de Marco R, Accordini S, Cerveri I, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004; 59: 120-125.
37. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995; 8: 1398-1420.
38. Mannino DM. Chronic obstructive pulmonary disease: definition and epidemiology. Respir Care 2003; 48: 1185-1191.
39. Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55: 789-794.
40. Cerveri I, Accordini S, Corsico A, et al. Chronic cough and phlegm in young adults. Eur Respir J 2003; 22: 413-417.
41. 1 among adult asthmatics. Eur Respir J 2003; 21: 95-100.
42. Fabbri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 418-424.
43. Bleecker ER. Similarities and differences in asthma and COPD. The Dutch hypothesis. Chest 2004; 126: Suppl. 2, 93S-95S.
44. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003; 124: 474-481.
45. Viegi G, Matteelli G, Angino A, et al. The proportional Venn diagram of obstructive lung disease in the Italian general population. Chest 2004; 126; 1093-1101.
46. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126: 59-65.
47. Stratelis G, Jakobsson P, Molstad S, Zetterstrom O. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract 2004; 54: 201-206.
48. Clotet J, Gomez-Arbones X, Ciria C, Albalad JM. Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care. Arch Bronconeumol 2004; 40: 155-159.
49. Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002; 324: 1370-1374.
50. Geijer RM, Sachs AP, Hoes AW, Salome PL, Lammers JW, Verheij TJ. Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old. Fam Pract 2005; 22: 485-489.
51. Gorecka D, Bednarek M, Nowinski A, Puscinska E, Goljan-Geremek A, Zielinski J. Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest 2003; 123: 1916-1923.
52. Bednarek M, Gorecka D, Wielgomas J, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006; 61: 869-873.
53. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002; 20: 799-805.
54. Miravitlles M, de la Roza C, Morera J, et al. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir Med 2006; 100: 1973-1980.
55. Mohangoo AD, van der Linden MW, Schellevis FG, Raat H. Prevalence estimates of asthma or COPD from a health interview survey and from general practitioner registration: what's the difference? Eur J Public Health 2006; 16: 101-105.
56. Cricelli C, Mazzaglia G, Samani F, et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 2003; 25: 254-257.
57. Wagner PD, Viegi G, Luna CM, Fukuchi Y, Kvale PA, El Sony A. Major causes of death in China. N Engl J Med 2006; 354: 874-876.
58. He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med 2005; 353: 1124-1134.
59. He J, Gu D, Whelton PK. Major causes of death in China. N Engl J Med 2006; 354: 874-876.
60. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640-2646.
61. Fuhrman C, Jougla E, Nicolau J, Eilstein D, Delmas M-C. Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis. Thorax 2006; 61: 930-934.
62. Gudmundsson G, Gislason T, Lindberg E, et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 2006; 7: 109-116.
63. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005; 128: 2005-2011.
64. Berger JS, Sanborn TA, Sherman W, Brown DL. Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am J Cardiol 2004; 94: 649-651.
65. Selvaraj CL, Gurm HS, Gupta R, Ellis SG, Bhatt DL. Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol 2005; 96: 756-759.
66. Kjoller E, Kober L, Iversen K, Torp-Pedersen C, Trace Study Group. Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction. Eur J Heart Fail 2004; 6: 71-77.
67. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068-2075.
68. Mapel DW, Dedrick D, Davis K. Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999. COPD 2005; 2: 35-41.
69. Hozawa A, Billings JL, Shahar E, Ohira T, Rosamond WD, Folsom AR. Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study. Chest 2006; 130: 1642-1649.
70. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005; 128: 2099-2107.
71. Kriegsman DM, Deeg DJ, Stalman WA. Comorbidity of somatic chronic diseases and decline in physical functioning: the Longitudinal Aging Study Amsterdam. J Clin Epidemiol 2004; 57: 55-65.
72. Mokhlesi B, Morris AL, Huang CF, Curcio AJ, Barrett TA, Kamp DW. Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest 2001; 119: 1043-1048.
73. Varma MG, Brown JS, Creasman JM, et al. Fecal incontinence in females older than aged 40 years: who is at risk? Dis Colon Rectum 2006; 49: 841-851.
74. Weerasuriya N, Snape J. A study of Candida esophagitis in elderly patients attending a district general hospital in the UK. Dis Oesophagus 2006; 19: 189-192.
75. Jorgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 2007; 101: 177-185.
76. Vermeeren MA, Creutzberg EC, Schols AM, et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006; 100: 1349-1355.
77. Guerra S, Sherrill DL, Baldacci S, et al. Rhinitis is an independent risk factor for developing cough apart from colds among adults. Allergy 2005; 60: 343-349.
78. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). Nord J Psychiatry 2004; 58: 65-70.
79. Wagena EJ, Kant I, Huibers MJ, et al. Psychological distress and depressed mood in employees with asthma, chronic bronchitis or emphysema: a population-based observational study on prevalence and the relationship with smoking cigarettes. Eur J Epidemiol 2004; 19: 147-153.
80. Carrasco Garrido P, de Miguel Diez J, Rejas Gutierrez J, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes 2006; 4: 31-39.
81. Sprenkle MD, Niewoehner DE, Nelson DB, Nichol KL. The Veterans Short Form 36 questionnaire is predictive of mortality and health-care utilization in a population of veterans with a self-reported diagnosis of asthma or COPD. Chest 2004; 126: 81-89.
82. Dal Negro R, Rossi A, Cerveri I. The burden of COPD in Italy: results from the Confronting COPD survey. Respir Med 2003; 97: Suppl. C, S43-S50.
83. Masa JF, Sobradillo V, Villasante C, et al. Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study. Arch Bronconeumol 2004; 40: 72-79.
84. Jansson SA, Andersson F, Borg S, Ericsson A, Jonsson E, Lundback B. Costs of COPD in Sweden according to disease severity. Chest 2002; 122: 1994-2002.
85. Detournay B, Pribil C, Fournier M, et al. The SCOPE study: health - care consumption related to patients with chronic obstructive pulmonary disease in France. Value Health 2004; 7: 168-174.
86. Bilde L, Rud Svenning A, Dollerup J, Baekke Borgeskov H, Lange P. The cost of treating patients with COPD in Denmark - a population study of COPD patients compared with non-COPD controls. Respir Med 2007; 101: 539-546.
87. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
88. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519-1527.
89. Eagan TM, Gulsvik A, Eide GE, Bakke PS. Remission of respiratory symptoms by smoking and occupational exposure in a cohort study. Eur Respir J 2004; 23: 589-594.
90. 1 decline in male working populations. Am Rev Respir Dis 1992; 146: 878-883.
91. Sherman CB, Xu X, Speizer FE, Ferris BG Jr, Weiss ST, Dockery DW. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992; 146: 855-859.
92. Sandvik L, Erikssen G, Thaulow E. Long term effects of smoking on physical fitness and lung function: a longitudinal study of 1393 middle aged Norwegian men for seven years. BMJ 1995; 311: 715-718.
93. Burchfiel CM, Marcus EB, Sharp DS, et al. Characteristics associated with rapid decline in forced expiratory volume. Ann Epidemiol 1996; 6: 217-227.
94. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002; 166: 675-679.
95. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381-390.
96. Henley SJ, Thun MJ, Chao A, Calle EE. Association between exclusive pipe smoking andmortality from cancer and other diseases. J Natl Cancer Inst 2004; 96: 853-861.
97. Ribarren C, Tekawa IS, Sidney S, Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med 1999; 340: 1773-1780.
98. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2006.
99. Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health 2005; 4: 7-14.
100. Eisner MD, Balmes J, Yelin EH, et al. Directly measured secondhand smoke exposure and COPD health outcomes. BMC Pulm Med 2006; 6: 12-22.
101. Garcia-Aymerich J, Farrero E, Felez MA, et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100-105.
102. Simoni M, Baldacci S, Puntoni R, et al. Respiratory symptoms/diseases and environmental tobacco smoke (ETS) in never smoker Italian women. Respir Med 2007; 101: 531-538.
103. Simoni M, Jaakkola MS, Carrozzi L, Baldacci S, Di Pede F, Viegi G. Indoor air pollution and respiratory health in the elderly. Eur Respir J 2003; 21: Suppl. 40, 15s-20s.
104. Jaakkola MS, Jaakkola JJ. Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention. Eur Respir J 2006; 28: 397-408.
105. Jimenez-Ruiz CA, Masa F, Miravitlles M, et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001; 119: 1365-1370.
106. Jimenez-Ruiz C, Miravitlles M, Sobradillo V, et al. Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease? Nicotine Tob Res 2004; 6: 649-653.
107. Tønnesen P, Carrozzi L, Fagerström KO, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 2007; 29: 390-417.
108. American Thoracic Society. What constitutes an adverse health effect of air pollution? Am J Respir Crit Care Med 2000; 161: 665-673.
109. Bernstein JA, Alexis N, Barnes C, et al. Health effects of air pollution. J Allergy Clin Immunol 2004; 114: 1116-1123.
110. Pope CA 3rd, Burnett RT, Thun MJ, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002; 287: 1132-1141.
111. Gryparis A, Forsberg B, Katsouyanni K, et al. Acute effects of ozone on mortality from the "Air Pollution and Health: a European Approach" project. Am J Respir Crit Care Med 2004; 170: 1080-1087.
112. Hoek G, Brunekreef B, Goldbohm S, Fischer P, van den Brandt PA. Association between mortality and indicators of traffic-related air pollution in the Netherlands: a cohort study. Lancet 2002; 360: 1203-1209.
113. Viegi G, Pedreschi M, Baldacci S, et al. Prevalence rates of respiratory symptoms and diseases in general population samples of North and Central Italy. Int J Tuberc Lung Dis 1999; 3: 1034-1042.
114. Iversen L, Hannaford PC, Price DB, Godden DJ. Is living in a rural area good for your respiratory health? Results from a cross-sectional study in Scotland. Chest 2005; 128: 2059-2067.
115. Xu F, Yin X, Zhang M, Shen H, Lu L, Xu Y. Prevalence of physician-diagnosed COPD and its association with smoking among urban and rural residents in regional mainland China. Chest 2005; 128: 2818-2823.
116. Schikowski T, Sugiri D, Ranft U, et al. Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res 2005; 6: 152-161.
117. Anderson HR, Spix C, Medina S, et al. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J 1997; 10: 1064-1071.
118. Yang Q, Chen Y, Krewski D, Burnett RT, Shi Y, McGrail KM. Effect of short-term exposure to low levels of gaseous pollutants on chronic obstructive pulmonary disease hospitalizations. Environ Res 2005; 99: 99-105.
119. Dominici F, Peng RD, Bell ML, et al. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA 2006; 295: 1127-1134.
120. Silkoff PE, Zhang L, Dutton S, et al. Winter air pollution and disease parameters in advanced chronic obstructive pulmonary disease panels residing in Denver, Colorado. J Allergy Clin Immunol 2005; 115: 337-344.
121. Sunyer J, Jarvis D, Gotschi T, et al. Chronic bronchitis and urban air pollution in an international study. Occup Environ Med 2006; 63: 836-843.
122. Gauderman WJ, Avol E, Gilliland F, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med 2004; 351: 1057-1067.
123. Gauderman WJ, Vora H, McConnell R, et al. Effect of exposure to traffic on lung development from 10 to 18 years of age: a cohort study. Lancet 2007; 369: 571-577.
124. Clancy L, Goodman P, Sinclair H, Dockery DW. Effect of air-pollution control on death rates in Dublin, Ireland: an intervention study. Lancet 2002; 360: 1210-1214.
125. Laden F, Schwartz J, Speizer FE, Dockery DW. Reduction in fine particulate air pollution and mortality: extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med 2006; 173: 667-672.
126. Viegi G, Simoni M, Scognamiglio A, et al. Indoor air pollution and airway disease. Int J Tuberc Lung Dis 2004; 8: 1401-1415.
127. Ekici A, Ekici M, Kurtipek E, et al. Obstructive airway diseases in women exposed to biomass smoke. Environ Res 2005; 99: 93-98.
128. Ramirez-Venegas A, Sansores RH, Perez-Padilla R, et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 2006; 173: 393-397.
129. Chapman RS, He X, Blair AE, Lan Q. Improvement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort study. BMJ 2005; 331: 1050-1055.
130. Driscoll T, Nelson DI, Steenland K, et al. The global burden of non-malignant respiratory disease due to occupational airborne exposures. Am J Ind Med 2005; 48: 432-445.
131. Balmes J, Becklake M, Blanc P, et al. American Thoracic Society Statement. Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003; 167: 787-797.
132. Bergdahl IA, Toren K, Eriksson K, et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J 2004; 23: 402-406.
133. Zock JP, Sunyer J, Kogevinas M, Kromhout H, Burney P, Anto JM. Occupation, chronic bronchitis, and lung function in young adults. An international study. Am J Respir Crit Care Med 2001; 163: 1572-1577.
134. Sunyer J, Zock JP, Kromhout H, et al. Lung function decline, chronic bronchitis, and occupational exposures in young adults. Am J Respir Crit Care Med 2005; 172: 1139-1145.
135. Matheson MC, Benke G, Raven J, et al. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax 2005; 60: 645-651.
136. Purdue MP, Gold L, Jarvholm B, Alavanja MC, Ward MH, Vermeulen R. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 2007; 62: 51-56.
137. Silverman EK. Genetic epidemiology of COPD. Chest 2002; 121: 1-6.
138. Cohen BH. Chronic obstructive pulmonary disease: a challenge in genetic epidemiology. Am J Epidemiol 1980; 112: 274-288.
139. Burrows B, Niden AH, Barclay WR, Kasik JE. Chronic obstructive lung disease II. Relationships of clinical and physiological findings to the severity of airways obstruction. Am Rev Respir Dis 1965; 91: 665-678.
140. Higgins M, Keller J. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J Chron Dis 1975; 28: 239-251.
141. Tager IB, Rosner B, Tishler PV, Speizer FE, Kass EH. Household aggregation of pulmonary function and chronic bronchitis. Am Rev Respir Dis 1976; 114: 485-492.
142. Kauffmann F, Tager IB, Munoz A, Speizer FE. Familial factors related to lung function in children aged 6-10 years: results from the PAARC epidemiologic study. Am J Epidemiol 1989; 129: 1289-1299.
143. Redline S, Tishler PV, Rosner B, et al. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. Am J Epidemiol 1989; 129: 827-836.
144. Coultas DB, Hanis CL, Howard CA, Skipper BJ, Samet JM. Heritability of ventilatory function in smoking and nonsmoking New Mexico Hispanics. Am Rev Respir Dis 1991; 144: 770-775.
145. Kurzius-Spencer M, Sherrill DL, Holberg CJ, Martinez FD, Lebowitz MD. Familial correlation in the decline of forced expiratory volume in one second. Am J Respir Crit Care Med 2001; 164: 1261-1265.
146. Chen Y, Horne SL, Rennie DC, Dosman JA. Segregation analysis of two lung function indices in a random sample of young families: the Humboldt family study. Genetic Epidemiol 1996; 13: 35-47.
147. Givelber RJ, Couropmitree NN, Gottlieb DJ, et al. Segregation analysis of pulmonary function among families in the Framingham study. Am J Respir Crit Care Med 1998; 157: 1445-1451.
148. 1 between asthmatic and non-asthmatic families: role of a maternal component. Am J Respir Crit Care Med 1998; 158: 162-169.
149. Rybicki BA, Beaty TH, Cohen BH. Major genetic mechanisms in pulmonary function. J Clin Epidemiol 1990; 43: 667-675.
150. Eriksson S. Pulmonary emphysema and alpha-1-antitrypsin deficiency. Acta Med Scand 1963; 175: 197-205.
151. World Health Organization. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ 1997; 75: 307-313.
152. Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 956 COPD patients. Chest 1986; 89: 370-373.
153. Molfino NA. Genetics of COPD. Chest 2004; 125: 1929-1940.
154. Kalsheker NA, Watkins GL, Hill S, et al. Independent mutations in the flanking sequence of the α1-antitrypsin gene are associated with chronic obstructive airways disease. Dis Marker 1990; 8: 151-157.
155. Schellenberg D, Pare PD, Weir TD, Spinelli JJ, Walker BA, Sandford AJ. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med 1998; 157: 957-961.
156. Gervais R, Lafitte JJ, Dumur V, et al. Sweat chloride and delta F508 mutation in chronic bronchitis or bronchiectasis. Lancet 1993; 342: 997.
157. Poller W, Faber JP, Scholz S, et al. Mis-sense mutation of alpha 1-antichymotrypsin gene associated with chronic lung disease. Lancet 1992; 339: 1538.
158. Smith CA, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350: 630-633.
159. Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T. Association of tumour necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 420-422.
160. Hersh CP, DeMeo DL, Lange C, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005; 33: 71-78.
161. Molfino NA. Current thinking on genetics of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2007; 13: 107-113.
162. Adcock IM, Ford P, Barnes PJ, Ito K. Epigenetics and airways disease. Respir Res 2006; 7: 21-39.
163. Viegi G, Prediletto R, Paoletti P, et al. Respiratory effects of occupational exposure in a general population sample in North Italy. Am Rev Respir Dis 1991; 143: 510-515.
164. Viegi G, Paoletti P, Carrozzi L, et al. Prevalence rates of respiratory symptoms in Italian general population samples, exposed to different levels of air pollution. Environ Health Perspect 1991; 94: 95-99.
165. Paoletti P, Prediletto R, Carrozzi L, et al. Effects of childhood and adolescence-adulthood respiratory infections in a general population. Eur Respir J 1989; 2: 428-436.
166. Vestbo J, Lange P. Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002; 166: 329-332.
167. American Medical Association. The respiratory system. In: Guides to the Evaluation of Permanent Impairment. 2nd Edn. Chicago, American Medical Association, 1984; pp. 85-107.
168. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
169. Miyamoto K, Aida A, Nishimura M, et al. Gender effect on prognosis of patients receiving long-term home oxygen therapy. Am J Respir Crit Care Med 1996; 152: 972-976.
170. Waterhouse JC, Nichol J, Howard P. Survey on domiciliary oxygen by concentrator in England and Wales. Eur Respir J 1994; 7: 2021-2025.
171. Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu JM. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest 1996; 109: 741-749.
172. Neri M, Melani AS, Miorelli AM, et al. Long-term oxygen therapy in chronic respiratory failure: a Multicenter Italian Study on Oxygen Therapy Adherence (MISOTA). Respir Med 2006; 100: 795-806.
173. Mitrouska I, Tzanakis N, Siafakas NM. Oxygen therapy in chronic obstructive pulmonary disease. In: Siafakas NM ed. Management of Chronic Obstructive Pulmonary Disease. Eur Respir Mon 2006; 38: 302-312.
174. Guyatt GH, Nonoyama M, Lacchetti C, et al. A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med 2005; 172: 573-580.
175. Strom K, Boe J. A national register for long-term oxygen therapy in chronic hypoxemia: preliminary results. Eur Respir J 1988; 1: 952-958.
176. Mortality data for COPD in 2002: statistical information. www.regione.toscana.it/cif/pubblica/mor021505/indic1505.htm. Date last accessed: June 30, 2007.
177. Croxton TL, Weinmann GG, Senio RM, Wise RA, Crapo JD, Buist AS. Clinical research in chronic obstructive pulmonary disease. Needs and opportunities. Am J Respir Crit Care Med 2003; 167: 1142-1149.
178. Croxton TL, Bailey CW. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med 2006; 174: 373-378.
179. Lloyd-Owen SJ, Donaldson GC, Ambrosino N, et al. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 2005; 25: 1025-1031.
180. Clini E, Sturani C, Rossi A, et al. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20: 529-538.
181. Association Nationale pour le Traitement à Domicile de l'Insuffisance Respiratoire chronique. 1998 yearly statistics. Observatoire 1998.
182. Janssens JP, Derivaz S, Breitenstein E, et al. Changing patterns in long-term non-invasive ventilation. A 7-year prospective study in the Geneva Lake area. Chest 2003; 123: 67-79.
183. Zoia MC, Corsico AG, Beccaria M, et al. Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. Respir Med 2005; 99: 1568-1575.
184. Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of COPD. Arch Intern Med 2003; 163: 1180-1186.
185. Confalonieri M, Garuti G, Cattaruzza MS, et al. Italian noninvasive positive pressure ventilation (NPPV) study group. A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J 2005; 25: 348-355.
186. Calverley PMA, Georgopoulos D. Chronic obstructive pulmonary disease: symptoms and signs. In: Siafakas NM, ed. Management of Chronic Obstructive Pulmonary Disease. Eur Respir Mon 2006; 38: 7-23.
187. Viegi G, Maio S, Pistelli F, Baldacci S, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution. Respirology 2006; 11: 523-532.
188. Kornmann O, Beeh KM, Beier J, Geis UP, Ksoll M, Buhl R. Global Initiative for Obstructive Lung Disease. Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease. Respiration 2003; 70: 67-75.
189. Brusasco V, Crapo R, Viegi G, American Thoracic Society, European Respiratory Society. Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J 2005; 26: 1-2.
190. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005; 26: 153-161.
191. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
192. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-522.
193. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735.
194. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
195. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20: 1117-1122.
196. Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS. Case definitions for chronic obstructive pulmonary disease. COPD 2006; 3: 95-100.
197. Pistelli F, Bottai M, Carrozzi L, et al. Reference equations for spirometry from a general population sample in central Italy. Respir Med 2007; 101: 814-825.
198. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005; 60: 842-847.
199. Perez-Padilla R, Hallal PC, Vazquez-Garcia JC, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007; 4: 113-120.
200. Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, Gulsvik A. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006; 173: 1316-1325.
201. Gibson GJ, MacNee W. Chronic obstructive pulmonary disease: investigations and assessment of severity. In: Siafakas NM, ed. Management of Chronic Obstructive Pulmonary Disease. Eur Respir Mon 2006; 38: 24-40.
202. Miravitlles M, Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, Segu JL. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration 2000; 67: 495-501.
203. Pistelli F, Viegi G. How to predict exacerbations and hospital admissions in stable COPD outpatients. Respiration 2000; 67: 491-492.
204. Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6: 98.
205. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 250-255.
206. Hurst JR, Donaldson GC, Perera WR, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174: 867-874.
207. Wouters EFM, ed. Systemic effects in chronic obstructive pulmonary disease. Eur Respir J 2003; 22: Suppl. 46.
208. Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease: a case-control study in a health maintenance organization. Arch Intern Med 2000; 160: 2653-2658.
209. Lynn J, Ely EW, Zhong Z, et al. Living and dying with chronic obstructive pulmonary disease. J Am Geriatr Soc 2000; 48: Suppl. 5, S91-S100.
210. Elkington H, White P, Addington-Hall J, Higgs R, Pettinari C. The last year of life of COPD: a qualitative study of symptoms and services. Respir Med 2004; 98: 439-445.
211. Stapleton RD, Nielsen EL, Engelberg RA, Patrick DL, Curtis JR. Association of depression and life-sustaining treatment preferences in patients with COPD. Chest 2005; 127: 328-334.
212. Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc 2000; 48: Suppl. 5, S146-S153.
213. Rabow MW, Dibble SL, Pantilat SZ, McPhee SJ. The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Arch Intern Med 2004; 164: 83-91.
214. Hill AT, Hopkinson RB, Stableforth DE. Ventilation in a Birmingham intensive care unit 1993-1995: outcome for patients with chronic obstructive pulmonary disease. Respir Med 1998; 92: 156-161.
215. Connors A Jr, Dawson N, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154: 959-967.
216. Moran JL, Green JV, Homan SD, Leeson RJ, Leppard PI. Acute exacerbations of chronic obstructive pulmonary disease and mechanical ventilation: a reevaluation. Crit Care Med 1998; 26: 71-78.
217. Ai-Ping C, Lee KH, Lim TK. In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD. A retrospective study. Chest 2005; 128: 518-524.
218. Christakis NA, Escarce JJ. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med 1996; 335: 172-178.
219. Nizet TA, van den Elshout FJ, Heijdra YF, van de Ven MJ, Mulder PG, Folgering HT. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia. Chest 2005; 127: 1904-1910.
220. Hersh CP, DeMeo DL, Al-Ansari E, et al. Predictors of survival in severe, early onset COPD. Chest 2004; 126: 1443-1451.
221. Marti S, Munoz X, Rios J, Morell F, Ferrer J. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 2006; 27: 689-696.